» Authors » Sophia I Pachydaki

Sophia I Pachydaki

Explore the profile of Sophia I Pachydaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 223
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaufman S, Yoganathan P, Small K, Rusia D, Pachydaki S, Conti S, et al.
J Vitreoretin Dis . 2023 Apr; 5(1):46-52. PMID: 37009583
Purpose: This work aims to determine whether previously defined genotype risk groups interact with Age-Related Eye Disease Study formulation (AREDS-F) use in progression to neovascular age-related macular degeneration (nvAMD). Methods:...
2.
Pachydaki S, Bhatnagar P, Barbazetto I, Klaver C, Freund B, Yannuzzi L
Retin Cases Brief Rep . 2014 Nov; 3(2):118-20. PMID: 25391051
Purpose: To report the long-term follow-up of a case of enhanced S-cone syndrome (ESCS). Methods: Retrospective chart review. Results: The patient was misdiagnosed with atypical retinitis pigmentosa at 17 years...
3.
Warden S, Pachydaki S, Paul T, DAmico D
Retin Cases Brief Rep . 2014 Nov; 3(4):429-30. PMID: 25389868
Purpose: To describe an intraocular contact lens presenting as a foreign body 1 year after repair of a traumatic open globe. Method: A case report. Results: The patient underwent open...
4.
Agemy S, Mehta A, Pachydaki S, Tewari A
Eur J Ophthalmol . 2014 Jan; 24(4):629-32. PMID: 24474376
Purpose: To describe a case of recurrent, bilateral panuveitis caused by the BRAF proto-oncogene inhibitor vemurafenib. Methods: Case report. Results: A 25-year-old woman developed bilateral panuveitis and macular edema after...
5.
Pachydaki S, Jakobiec F, Bhat P, Sobrin L, Michaud N, Seshan S, et al.
J Ophthalmic Inflamm Infect . 2011 Nov; 2(1):29-37. PMID: 22120962
Purpose: This study aims to describe surgical management results and the pathologic features of choroidal neovascularization (CNV) secondary to punctate inner choroidopathy (PIC) following anti-vascular endothelial growth factor treatment. Design:...
6.
Pachydaki S, Klaver C, Barbazetto I, Roy M, Gouras P, Allikmets R, et al.
Arch Ophthalmol . 2009 Jan; 127(1):71-5. PMID: 19139342
Objective: To describe the phenotypes of 5 patients with NR2E3 mutations. Methods: Two patients with familial and 3 with sporadic early-onset nyctalopia and retinal pigment abnormalities were screened for mutations...
7.
Pachydaki S, Young L
Semin Ophthalmol . 2007 Dec; 22(4):219-27. PMID: 18097985
The hereditary vitreoretinal disorders have variable vitreoretinal and other ocular and skeletal abnormalities. Some of these conditions represent a spectrum of clinical disease. This, along with the phenotypic variability, often...
8.
Warden S, Pachydaki S, Christoforidis J, DAmico D, Loewenstein J
Arch Ophthalmol . 2006 Nov; 124(11):1652-4. PMID: 17102017
No abstract available.
9.
Pachydaki S, Tari S, Lee S, Ma W, Tseng J, Sosunov A, et al.
Exp Eye Res . 2005 Dec; 82(5):807-15. PMID: 16364297
We sought to study the presence of the receptor for advanced glycation endproducts (RAGE) and its ligands, advanced glycation endproducts (AGEs), S100/calgranulins and amphoterin (high mobility group box 1 protein;...
10.
Barile G, Pachydaki S, Tari S, Lee S, Donmoyer C, Ma W, et al.
Invest Ophthalmol Vis Sci . 2005 Jul; 46(8):2916-24. PMID: 16043866
Purpose: The receptor for advanced glycation end products (AGEs) has been implicated in the pathogenesis of diabetic complications. This study was conducted to characterize the role of the RAGE axis...